Neurizon Therapeutics Limited (“Neurizon”), a clinical-stage biotech company dedicated to advancing treatments for ...

Neurizon Therapeutics (ASX: NUZ) has announced encouraging outcomes from an independent study assessing its neuroprotective ...

Neurizon Therapeutics (ASX: NUZ) has reported positive results from an independent study into the effects of neuroprotective ...

NUZ-001 has shown it promotes healthy and viable brain tissues, potentially demonstrating its use to treat Alzheimer’s and ...

Mach 7 and Universal Biosensors have announced their CEOs will depart, while changes at the top are likely at other biotechs.

Neurizon Therapeutics Ltd (ASX:NUZ) has yielded positive results from an independent study – conducted in collaboration with ...

NUZ-001 slowed respiratory declines in ALS patients in a Phase 1 trial, and Neurizon is working to ready it for the HEALEY ...

Several ASX healthcare companies are leading the charge in finding new treatments for complex neurological disorders.

Stockhead’s Break it Down brings you today’s leading market news in under 90 seconds. In this episode, Tylah Tully gives the ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Neurizon Therapeutics plans to implement several initiatives to get the clinical hold lifted of its IND application for NUZ-001. The company has been in discussion with the US FDA since February ...